אנטרסטו 50 מג  ישראל - עברית - Ministry of Health

אנטרסטו 50 מג

novartis israel ltd - sacubitril/valsartan as sodium salt complex - טבליות מצופות פילם - sacubitril/valsartan as sodium salt complex 24/26 mg - valsartan and sacubitril

אנטרסטו 50 מג  ישראל - עברית - Ministry of Health

אנטרסטו 50 מג

novartis israel ltd - sacubitril/valsartan as sodium salt complex - טבליות מצופות פילם - sacubitril/valsartan as sodium salt complex 24/26 mg - valsartan and sacubitril

אנטרסטו 50 מג  ישראל - עברית - Ministry of Health

אנטרסטו 50 מג

novartis israel ltd - sacubitril/valsartan as sodium salt complex - טבליות מצופות פילם - sacubitril/valsartan as sodium salt complex 24/26 mg - valsartan and sacubitril

ראסילז 150 מ"ג ישראל - עברית - Ministry of Health

ראסילז 150 מ"ג

novartis pharma services ag - aliskiren 150 mg - film coated tablets - aliskiren - treatment of essential hypertension.

ראסילז 300 מ"ג ישראל - עברית - Ministry of Health

ראסילז 300 מ"ג

novartis pharma services ag - aliskiren 300 mg - film coated tablets - aliskiren - treatment of essential hypertension.

סביבו ישראל - עברית - Ministry of Health

סביבו

novartis pharma services ag - telbivudine 600 mg - film coated tablets - telbivudine - treatment of chronic hepatitis b in patients with evidence of viral replication and active liver inflammation in adults over 16 years of age.the following points should be considered when initiating therapy with sebivo:- for hbeag - positive patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 9log 10 copies/ml and baseline alt>or= 2x uln.- for hbeag - negative patients, sebivo treatment should only be initiated in patients with baseline hbv dna < 7log 10 copies/ml.

גליבק ® 100 מ"ג ישראל - עברית - Ministry of Health

גליבק ® 100 מ"ג

novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l

מיפורטיק 180 מ"ג ישראל - עברית - Ministry of Health

מיפורטיק 180 מ"ג

novartis pharma services ag - mycophenolic acid 180 mg - film coated tablets - mycophenolic acid - myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

מיפורטיק 360 מ"ג ישראל - עברית - Ministry of Health

מיפורטיק 360 מ"ג

novartis pharma services ag - mycophenolic acid 360 mg - film coated tablets - mycophenolic acid - myfortic is indicated in combination with ciclosporin and corticosteroids for the prophylaxis of acute transplant rejection in adult patients receiving allogeneic renal transplants.

וקטור 160 ישראל - עברית - Ministry of Health

וקטור 160

unipharm ltd, israel - valsartan - טבליה - valsartan 160 mg - valsartan - valsartan - for treatment of hypertension. valsartan is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan significantly reduced hospitalizations for heart failure. there is no evidence that valsartan provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.